Bu liste, son piyasa olaylarına dayalı bir analizdir. Yatırım tavsiyesi değildir.
Hakkında
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Show more...
CEO
Roger Tung
Çalışanlar
64
Ülke
US
ISIN
US2060221056
WKN
000A1XEAC
Kotasyonlar
0 Comments
Düşüncelerini paylaş
FAQ
Concert Pharmaceuticals hissesinin bugünkü fiyatı nedir?▼
CNCE’un güncel fiyatı $8.37 USD — son 24 saatte %+0.12% arttı. Concert Pharmaceuticals hissesinin fiyat performansını grafikte daha yakından izle.